Navigation Links
Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
Date:11/29/2007

PHILADELPHIA, Nov. 29 /PRNewswire/ -- As part of an ongoing commitment to help clients reduce product development times and maximize commercial impact of their products, Premier Research Group plc (AIM: PRG) announced today the consolidation of its industry-leading expertise in its core service areas into a single group, Strategic Product Development (SPD).

The expertise within the group closely matches Premier Research's focus on clinical research services in neuroscience, analgesia, oncology, infectious disease, and pediatrics. It also reflects the firm's strength in medical device development, adaptive clinical trials design, and state of the art clinical trial related technologies.

"Client demand is driving this," explained Premier Research Group COO Dr. Troy McCall. "Cost and commercialization pressures have our clients focused on leveraging the insights and expertise gained from the hundreds of studies we conduct each year. We're being asked to become involved earlier and more substantively which is great because it leads to better and more efficient studies."

Dr. McCall added that, "Strategic Product Development, in collaboration with a strong Global Regulatory Affairs capability, reflects the company's deep commitment to being a 'solution provider' for our clients. We're routinely told that this philosophy is an important differentiator for us relative to our competitors, and we've dedicated ourselves to continually building upon this strength."

The group will be led by Samer E. Kaba, MD, Vice President, Global Medical Affairs and SPD and include the following experts:
-- Bernard Brownstein, MD, Vice President, Medical Affairs and SPD --

Pediatrics

-- Luciano Fuccella, MD, Vice President, Medical Affairs and SPD --

Clinical Pharmacology

-- Danielle Giroud, RN, MBA, Vice President, SPD -- Medical Devices

-- Sid Jevons, PhD, Vice President, SPD -- Infectious Diseases

-- Mike Kuss, Vice President, SPD -- Analgesia

-- Thomas Ng, MD, MBA, CPI, Senior Director, Medical Affairs and SPD --

Hematology/Oncology

-- Ajay Sadhwani, Executive Director, SPD -- Clinical Trial Informatics

-- Bruce Stouch, PhD, Vice President, SPD -- Adaptive Trial Design

About Premier Research

Premier Research is a leading solutions-driven CRO leveraging our commitment to therapeutic focus and scientific expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for Analgesia, CNS, Infectious Disease, and Oncology and have a wealth of experience in medical device and pediatric research. Premier Research has 29 offices and operates in more than 30 countries across Europe and North America. They employ a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at a well-established network of dedicated clinical sites.


'/>"/>
SOURCE Premier Research Group plc
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
2. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
3. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
4. IsoTis Receives FDA Clearance for Accell Family of Products
5. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
6. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
9. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
10. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
11. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... In a list published ... of the state’s 76 fastest-growing private companies; a small percentage of the state's 615,000+ ... organizations on the percent change in revenue from 2012 to 2015. , ...
(Date:5/3/2016)... ... May 03, 2016 , ... Flagship Biosciences, ... Nancy Gillett to its Board of Directors. Dr. Gillett recently retired from Charles ... Vice President and Chief Scientific Officer. A board-certified veterinary pathologist, Dr. Gillett joined ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... NeuroTech NYC , the sensor and data driven conferences, will take place on June 7-8, 2016, ... UnitedHealth's Vidya Raman-Tangella on incorporating technology -- including AR/VR, machine learning, apps, ...
(Date:5/3/2016)... , May 3, 2016  Dr. Thomas ... surgeon in The Woodlands, Texas , ... 24 percent of treated fat cells in just 25-minutes, ... Close to 90 percent of Americans report feeling bothered ... Nonsurgical fat reduction procedures are a growing industry. This ...
Breaking Biology Technology:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
Breaking Biology News(10 mins):